与可能来自蝙蝠的新型冠状病毒相关的肺炎疫情
Peng Zhou1, Xing-Lou Yang1, Xian-Guang Wang2
1CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
Nature
|February 5, 2020
概括
一种新的冠状病毒,2019-nCoV在武汉引起了严重急性呼吸系统综合征 (SARS) 疫情. 这种病毒与蝙蝠中发现的与SARS相关的冠状病毒 (SARSr-CoV) 密切相关,并使用相同的细胞进入受体.
科学领域:
- 病毒学
- 流行病学
- 基因组学
背景情况:
- 严重急性呼吸系统综合征 (SARS) 爆发与蝙蝠冠状病毒有关.
- 之前的研究表明一些蝙蝠SARS相关的冠状病毒 (SARSr-CoVs) 对人类的潜在感染性.
研究的目的:
- 鉴定和鉴定新型冠状病毒 (2019-nCoV) 导致中国武汉的人类呼吸系统综合征疫情.
- 研究2019-nCoV与已知的冠状病毒及其细胞进入机制的基因组关系.
主要方法:
- 从患者样本中对2019-nCoV的全基因组测序.
- 与SARS-CoV和蝙蝠冠状病毒进行基因组比较分析.
- 对保存的非结构蛋白域进行分析.
- 细胞进入受体的识别.
主要成果:
- 截至2020年1月26日,该流行病涉及2794例确诊感染和80例死亡.
- 在整个基因组层面上,2019-nCoV与SARS-CoV共享79.6%的序列特征,与蝙蝠冠状病毒共享96%.
- 蛋白质序列分析证实2019-nCoV属于SARSr-CoV物种.
- 这种病毒利用血管激素转化酶II (ACE2) 作为细胞进入受体,类似于SARS-CoV.
- 患者血清表现出对病毒的中和能力.
结论:
- 2019-nCoV 是一种与蝙蝠冠状病毒具有显著基因组相似性的新型SARSr-CoV.
- 病毒使用ACE2进入细胞的能力是其致病的一个关键因素.
- 了解2019-nCoV的起源和特征对于管理正在进行的流行病至关重要.
相关概念视频
Pneumonia I: Introduction
656
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
656
Pneumonia II: Pathophysiology
2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Viral Recombination
24.8K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.8K
Pneumonia III: Complications and Assessment
720
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
720
Pneumonia V: Nursing management and Prevention
3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia IV: Management
690
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
690


